19 Recruiting Trials

Clinical Trials
for Lupus in Ohio

19 clinical trials for Lupus are currently recruiting participants at study sites in Ohio. Study-related care is provided at no cost.

19
Recruiting trials
21
Study sites
5
Cities
13
Industry-sponsored
6
Phase 2
4
Phase 3

Lupus clinical trials in Ohio: what to expect

Lupus trials are mostly for systemic lupus that stays active despite standard treatment. They test biologic infusions and injections that target the immune signals behind lupus, new oral medicines, and treatments that reduce the need for steroids. Lupus nephritis, where the disease affects the kidneys, has its own trials with their own entry rules, and cell-based therapies are beginning to be tested in people whose lupus has not responded to anything else.

In Ohio, recruiting lupus studies are concentrated in Cleveland, Columbus, Cincinnati and Middleburg Heights, with sites in 1 other city. 13 of the 19 are run by a drug or device company, which usually means a larger study with travel reimbursement; the rest are academic or hospital-led.

Who lupus trials usually look for

Trials require a confirmed diagnosis with positive antibody tests, active disease above a threshold on a standard activity score at screening, and a stable regimen of your current medicines (an antimalarial, an immunosuppressant, a steroid below a stated dose) for several weeks beforehand. Lupus nephritis trials need a recent kidney biopsy and a protein-in-urine level above a cut-off. Common exclusions are severe active lupus of the brain, a recent biologic, serious infection and pregnancy. Ages are usually 18 to 75.

What taking part involves

Screening includes blood and urine tests and a review of your records. Most trials then last a year with visits every four weeks for an infusion or injection, lab monitoring and a disease-activity exam, often with a plan to taper steroids. The study drug is usually compared with placebo, both added to your existing treatment, and flares are treated as needed. An open-label extension generally follows. All study care is free and visits are usually paid.

Questions worth asking the study team

Whether your current medicines stay unchanged; how the steroid taper works; the chance of placebo and whether an extension follows; what happens during a flare; and what the trial means for pregnancy planning.

Showing 19 of 19 recruiting Lupus trials in Ohio

Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
PHASE3 Anniston, Alabama +4 sites NCT06133972
This trial is looking for people with systemic lupus erythematosus who have completed a previous study using ianalumab. Participants will be monitored for long-term safety and tolerance of the treatment.
Recruiting
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
PHASE3 Phoenix, Arizona +4 sites NCT05835310
This trial is looking for children with moderate to severe systemic lupus erythematosus (SLE) to test a treatment called Anifrolumab. Participants will be monitored to understand how well the treatment works and its safety.
Recruiting
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
PHASE3 Beverly Hills, California +4 sites NCT07438496
This trial is looking for adults with moderate to severe lupus. Participants will receive either the drug nipocalimab or a placebo to see how well it works.
Recruiting
A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
PHASE2 Beverly Hills, California +4 sites NCT07409181
This trial is looking for adults with systemic lupus erythematosus (SLE) to see if a medicine called BI 3000202 can help them. Participants will take the medicine or a placebo for one year while continuing their regular SLE treatment.
Recruiting
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
PHASE2 Loma Linda, California +4 sites NCT05039619
This trial is looking for teenagers aged 12 to 18 and children aged 5 to under 12 who have been diagnosed with lupus nephritis. Participants will receive treatment with obinutuzumab and be monitored for safety and effectiveness.
Recruiting
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
PHASE2 Phoenix, Arizona +4 sites NCT05268289
This trial is looking for people with active lupus nephritis. Participants will take a medication called LNP023 along with their usual treatment to see how well it works and how safe it is.
Recruiting
The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study
PHASE2 San Francisco, California +4 sites NCT05538208
This trial is looking for young people aged 8 to 20 with lupus nephritis. Participants will take a medication called Mycophenolate Mofetil and visit the study site regularly for assessments.
Recruiting
Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders
PHASE1 Cincinnati, Ohio +2 sites NCT07089121
This trial is looking for children, adolescents, and young adults aged 12 and up who have been diagnosed with certain autoimmune disorders. Participants will receive the treatment Descartes-08 to see how well it works and whether it is safe to use.
Recruiting
Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial
PHASE4 Columbus, Ohio +4 sites NCT07225387
This trial is looking for adults with lupus nephritis to see if a combination of two medications helps improve kidney function. Participants will receive treatments and undergo health assessments over time.
Recruiting
A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants
PHASE1 Columbus, Ohio +4 sites NCT06576271
This trial is looking for healthy individuals and people with systemic lupus erythematosus (SLE) to evaluate a new treatment. Participants will undergo medical evaluations and may need to provide blood samples.
Recruiting
BAFF CAR-T Cells (LMY-920) for Systemic Lupus Erythematosus
PHASE1 Columbus, Ohio NCT06340750
This trial is looking for adults aged 18-69 with difficult-to-treat systemic lupus erythematosus. Participants will receive a new type of treatment called BAFF-ligand CAR-T cells to see if it is safe and effective.
Recruiting
Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus
NA Cincinnati, Ohio +4 sites NCT06232304
This trial is looking for young people with childhood-onset lupus to join a program that helps them learn to cope with fatigue, pain, and depression. Participants will receive this support alongside their regular medical care.
Recruiting
Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN
N/A Columbus, Ohio +4 sites NCT06527872
This trial is looking for adults with lupus nephritis who have been treated with belimumab in the past 6 to 24 months. Participants will help understand how well this treatment works over time in real-life situations.
Recruiting
Lupus Landmark Study: A Prospective Registry and Biorepository
N/A Birmingham, Alabama +4 sites NCT05934149
This trial is looking for adults aged 18 or older who have been diagnosed with systemic lupus erythematosus (SLE), including lupus nephritis. Participants will help gather important data and samples for future research.
Recruiting
Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment
PHASE3 Phoenix, Arizona +4 sites NCT07691970
This trial is looking for people who have finished another study with anifrolumab and are still benefiting from it. Participants will continue to receive anifrolumab and will be monitored for safety.
Recruiting
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
PHASE2 Scottsdale, Arizona +4 sites NCT06570798
This trial is looking for adults with systemic lupus erythematosus or rheumatoid arthritis. Participating involves receiving treatment with inebilizumab or blinatumomab and attending follow-up visits to monitor your health.
Recruiting
Biopsychosocial Risk Influences on the Development and Generation of Early-Onset Chronic Pain
N/A Cincinnati, Ohio NCT07602595
This trial is looking for young people aged 14 to 26 who have long-lasting muscle and bone pain or a related condition. Participants will help researchers understand different types of pain and what factors may contribute to it.
Recruiting
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
PHASE1 Birmingham, Alabama +4 sites NCT03816345
This trial is looking for adults with advanced cancers who also have autoimmune disorders. Participants will receive treatments that may include the drug nivolumab and possibly others to see how well they work together.
Recruiting
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
PHASE1 Beverly Hills, California +4 sites NCT06308978
This trial is looking for people between the ages of 12 and 70 who have certain autoimmune diseases that are not responding to previous treatments. They should generally be in good health, but not have serious heart or lung problems, active infections, or recent cancer. Also, women can't be pregnant or breastfeeding, and participants need to weigh at least 50 kg.
Recruiting

Where the Lupus studies are in Ohio

  • Cincinnati Children's Hospital Medical Center, Cincinnati3 trials
  • Cleveland Clinic Foundation, Cleveland2 trials
  • GSK Investigational Site, Columbus2 trials
  • Research Site, Cleveland2 trials
  • Akron Children's Hospital, Akron1 trial
  • Cincinnati Children's Hospital, Cincinnati1 trial

Counts are recruiting studies listing at least one site in Ohio, from ClinicalTrials.gov, refreshed every two days.

Lupus clinical trials in Ohio: common questions

How many Lupus clinical trials are recruiting in Ohio?
TrialFinder currently lists 19 recruiting Lupus clinical trials with study sites in Ohio. Results are updated regularly from ClinicalTrials.gov, the official U.S. registry of clinical studies.
Where are Lupus clinical trials located in Ohio?
Study sites for the Lupus trials listed on this page include Cincinnati, Columbus. Each trial page lists every participating site with contact details, so you can find the location closest to you.
Do I need insurance to join a Lupus clinical trial in Ohio?
No. Study-related care is covered by the trial sponsor at no cost to participants, including the study treatment, required lab tests and study visits. Many Lupus trials in Ohio also compensate participants for time and travel. Health insurance is not required to search or enroll.
How do I qualify for a Lupus clinical trial in Ohio?
Each study sets its own criteria based on age, Lupus diagnosis details, prior treatments, current medications and general health. The fastest way to find out is to contact a research site directly — most will pre-screen you by phone in 10 to 15 minutes at no charge. You can also create a free TrialFinder profile to be matched automatically.
Will my regular lupus medicines stop if I join a trial?
No. Lupus trials add the study treatment to a stable regimen of your current medicines. Many include a planned steroid taper as one of the goals, managed by the study doctor.
Is there a placebo in lupus trials?
Usually, but always on top of standard treatment, never instead of it, and most trials move everyone onto the active drug in an extension after the main study period.
Can I join a trial if I have lupus nephritis?
Yes. Lupus nephritis has dedicated trials that require a recent kidney biopsy and a stated level of protein in the urine. General lupus trials often exclude active nephritis, so look for the ones that name it.
Are Clinical Trials Safe? What Patients Should Know
How clinical trial safety works — phases, IRB oversight, informed consent, and your right to withdraw — plus the real risks and questions to ask.
How to Know If You Qualify for a Clinical Trial
Every trial has eligibility criteria based on diagnosis, age, and medical history. Here's how to tell if you qualify — and what to do if you're not sure.
Clinical Trials Without Insurance: What You Need to Know
Clinical trials cover the cost of study-related care, making them one of the few ways to access treatment without health insurance. Here's what's covered.
All guides →

Check Your Eligibility

Create a free profile and our AI will match you to Lupus trials near you in Ohio.

Get Matched — Free
No insurance required

Lupus trials evaluate belimumab, anifrolumab, JAK inhibitors, and other biologics targeting the immune dysregulation behind systemic lupus erythematosus.

All Lupus trials →